Ardelyx (ARDX) vs SL Science (SLBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Ardelyx (ARDX) has outperformed SL Science (SLBT) over the past year, losing 36.9% versus a loss of 85.4%. SL Science is the larger company by market cap ($858.0 million vs $843.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARDX | SLBT |
|---|---|---|
| Share price | $3.27 | $1.53 |
| Market cap | $842.98M | $857.96M |
| 1-day change | +0.15% | +1.32% |
| YTD return | -44.08% | -85.68% |
| 1-year return | -36.94% | -85.42% |
| 5-year return | +201.85% | — |
| Forward P/E | 11.24 | — |
| EPS (TTM) | $-0.23 | $-0.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.40 | $14.50 |
| 52-week low | $3.18 | $1.42 |
| Distance from 52-week high | -61.13% | -89.45% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +295.10% | — |
| Average volume | 4.10M | 80.93K |
| Shares outstanding | 258.19M | 560.76M |
| Employees | 489 | 14 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ARDX has outperformed SLBT by 48.5 percentage points over the past year.
About Ardelyx
ARDX stock →Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 489 employees
About SL Science
SLBT stock →SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 14 employees
ARDX vs SLBT FAQ
Which is bigger, Ardelyx or SL Science?
SL Science (SLBT) is larger, with a market capitalization of $857.96M compared with $842.98M for Ardelyx (ARDX).
Which stock has performed better over the past year, ARDX or SLBT?
ARDX returned -36.94% over the past 12 months, compared with -85.42% for SLBT (price return, excluding dividends). Past performance does not predict future results.
Are Ardelyx and SL Science in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Ardelyx and Biotechnology: Biological Products (No Diagnostic Substances) for SL Science.